BSEAstal Laboratories LtdMinimalNeutral
Announced Thu, 19 Mar · 22:55 IST

Submission of Intimation under Regulation 7 (2) of SEBI (PIT) Regulations, 2015.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹74.50
prior close
₹75.98
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0-0.0-1.4-2.4-9.9-9.8-8.6-9.0-4.7-9.9-10.5+5.5+7.4
Up moveDown movePending
AI summary

Astal Laboratories Ltd has informed BSE that it received a disclosure from its Promoter, Aceso Research Labs LLP, regarding the purchase of equity shares of the company. The disclosure was made under Regulation 7(2) read with Regulation 6(2) of SEBI's Prohibition of Insider Trading Regulations, 2015, via Form C. The intimation is signed by Mahendra Kumar, Company Secretary & Compliance Officer, and the promoter's disclosure is signed by Ravi Kant Shailaja, Designated Partner of Aceso Research Labs LLP. The specific number of shares purchased and the transaction value are not mentioned in this filing.

Likely market impact

Promoter share purchases are generally viewed as a confidence signal by retail investors, suggesting insiders believe the stock is undervalued. However, the absence of share quantity and price details in this intimation limits how much investors can gauge the scale of the buying.